uridine has been researched along with Chronic Progressive External Ophthalmoplegia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardaioli, E; Da Pozzo, P; Dotti, MT; Federico, A; Radi, E | 1 |
| Berti, G; Cardaioli, E; Da Pozzo, P; Dotti, MT; Federico, A; Gallus, GN; Gambelli, S; Gaudiano, C; Malandrini, A; Malfatti, E; Serni, G; Viscomi, C; Zicari, E | 1 |
2 other study(ies) available for uridine and Chronic Progressive External Ophthalmoplegia
| Article | Year |
|---|---|
A novel heteroplasmic tRNA(Leu(CUN)) mtDNA point mutation associated with chronic progressive external ophthalmoplegia.
Topics: Animals; Base Sequence; DNA, Mitochondrial; Fibroblasts; Humans; Lymphocytes; Mitochondrial Myopathies; Muscle Fibers, Skeletal; Ophthalmoplegia, Chronic Progressive External; Point Mutation; Polymorphism, Restriction Fragment Length; RNA, Transfer, Leu; Uridine | 2005 |
A novel heteroplasmic tRNA(Ser(UCN)) mtDNA point mutation associated with progressive external ophthalmoplegia and hearing loss.
Topics: Adult; DNA Mutational Analysis; DNA, Mitochondrial; Female; Hearing Loss; Humans; Male; Ophthalmoplegia, Chronic Progressive External; Point Mutation; Polymorphism, Restriction Fragment Length; RNA, Transfer, Ser; Uridine | 2007 |